Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. scores highest on Anchor (45) and lowest on Price (17). Its PosiPenta is 31.09 out of 100, weaker than most similar companies.
On the Penta Grid this week, Dyne Therapeutics, Inc. is Grid #744 of 837 in the Healthcare sector in United States, and Grid #3,555 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | 31.09 | 17 | 22 | 36 | 35 | 45 |
| Privia Health Group, Inc. | 63.72 | 22 | 87 | 72 | 77 | 62 |
| Aveanna Healthcare Holdings Inc. | 56.68 | 48 | 50 | 86 | 52 | 48 |
| Acadia Healthcare Company, Inc. | 51.36 | 34 | 45 | 86 | 35 | 57 |
| Disc Medicine, Inc. | 38.80 | 20 | 16 | 57 | 54 | 48 |
| Denali Therapeutics Inc. | 44.02 | 20 | 29 | 62 | 53 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.32 |
| P/B ratio | 3.79 |
EEarnings
| Trailing EPS | ₹-312.56 |
| Forward EPS | ₹-315.89 |
NNitro
| Price | 1349.69 |
| 52-week high | 2586.19 |
| 52-week low | 1326.01 |
| Fall from 52-week high | 47.8% |
TTorque
| Return on equity (ROE) | -81.56% |
| Debt-to-equity | 0.33 |
AAnchor
| Beta (price swings) | 1.12 |
| Market cap | ₹25,204 Cr |
| Insider holding | 0.24% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Dyne Therapeutics, Inc.'s PosiPenta score?
Dyne Therapeutics, Inc.'s PosiPenta is 31.09 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Dyne Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Dyne Therapeutics, Inc. is Grid #744 of 837 in the Healthcare sector in United States, and Grid #3,555 of 4,000 in United States.
Which PosiPenta pillar is strongest for Dyne Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 45 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Dyne Therapeutics, Inc.?
Price (valuation), with a score of 17 out of 100: much weaker than most similar companies.
Has Dyne Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.87 points, from 29.22 to 31.09.
PositoAI is for research and education only and is not investment advice.